NewsNovo
UnitedHealth Group CFO Wayne DeVeydt stated on the third-quarter earnings call that current analyst consensus for 2027 may understate the company's earnings opportunity, a claim that follows the stock's 17% rise this year.
The company reported adjusted earnings of $4.69 per share, beating the $4.14 analyst consensus, and raised its full-year 2026 adjusted earnings outlook to at least $20.50 per share from a previous range of $19.50 to $20.
DeVeydt characterized the quality of earnings as strong and durable as the company heads into 2027.
He identified the lower end of UnitedHealth's long-term adjusted earnings growth target of 13% to 16% as a reasonable starting point for future performance.
Keep reading